bioAffinity Technologies Inc - Warrant — Quarterly Balance Sheet (NASDAQ:BIAFW)

Financials

Total revenue 2.35 M2.21 M1.85 M1.27 M1.45 M 6.78 M Gross profit 2.35 M2.21 M1.85 M1.27 M1.45 M 6.78 M Operating expenses 4.32 M5.15 M4.48 M3.79 M3.74 M 17.16 M Selling/general/admin expenses 2.36 M2.92 M2.45 M2.21 M2.21 M 9.8 M Research & development 274.5 K390.66 K367.39 K311.37 K330.59 K 1.4 M Operating income -1.97 M-2.95 M-2.63 M-2.52 M-2.29 M -10.38 M Non-Operating Income, Total -24.42 K-20.34 K-24.58 K-1.52 M-2.76 M -4.32 M Interest expense, net of interest capitalized 21.63 K25.05 K15.48 K10.46 K5 358 56.35 K Non-Operating Income, excl. Interest Expenses -41.03 K-46.02 K-30.43 K-1.08 M-2.76 M -3.92 M Unusual income/expense -5 014632-9 640-444.99 K-3 326 -457.32 K Pretax income -2 M-2.97 M-2.65 M-4.03 M-5.05 M -14.7 M Equity in earnings ————— — Taxes 2 55908 69528.98 K3 182 40.86 K Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -2 M-2.97 M-2.66 M-4.06 M-5.05 M -14.74 M Discontinued operations ————— — Net income -2 M-2.97 M-2.66 M-4.06 M-5.05 M -14.74 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -2 M-2.97 M-2.66 M-4.06 M-5.05 M -14.74 M Basic earnings per share (Basic EPS) -4.8-5.96-4.8-5.1-4.74 -20.6 Diluted earnings per share (Diluted EPS) -4.8-5.96-4.8-5.1-4.74 -20.6 Average basic shares outstanding 413.06 K404.17 K541.92 K800.72 K1.07 M 2.81 M Diluted shares outstanding 413.06 K404.17 K541.92 K800.72 K1.07 M 2.81 M EBITDA ————— — EBIT ————— — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 180.47 K69.06 K154.59 K127.81 K142.53 K 493.98 K